Patent Assignment
Reel/Frame 069359/0921
Release of Security Interest
Recorded: 2024-11-14
Pages: 25
Assignor
ORBIMED ROYALTY & CREDIT OPPORTUNITIES III, LP
Executed: 2024-11-13
Assignees
NEURELIS, INC.
3430 CARMEL MOUNTAIN ROAD, SUITE 300, SAN DIEGO, CALIFORNIA, 92121
AEGIS THERAPEUTICS, LLC
3430 CARMEL MOUNTAIN ROAD, SUITE 300, SAN DIEGO, CALIFORNIA, 92121
Covered Properties
(71)
Absorption Enhancers for Drug Administration
Application:
16/898,365 →
Publication:
US US20210121573A1
Compositions, Devices and Methods for the Treatment of Alcohol Use Disorder
Application:
16/311,944 →
Publication:
US US20190209464A1
Compositions, Devices, and Methods for the Treatment of Opioid-Receptor-Mediated Conditions
Application:
17/024,149 →
Publication:
US US20210077382A1
Formulations and Methods for the Prevention of Opioid Overdose
Application:
17/055,647 →
Publication:
US US20210220346A1
Compositions, Devices, and Methods for the Treatment of Overdose and Reward-Based Disorders
Application:
16/721,872 →
Publication:
US US20200390691A1
Peptide Compositions and Methods of Use
Application:
16/615,362 →
Publication:
US US20200197494A1
Compositions for Drug Administration
Oil-Soluble Drug Containing Compositions and Methods of Use Thereof
Application:
16/875,683 →
Publication:
US US20200360292A1
Methods and Compositions for Rapid Delivery of Anti-Seizure Therapeutics
Application:
63/135,291 →
Multimodal Particulate Formulations
Application:
16/594,897 →
Publication:
US US20200038320A1
Administration of Benzodiazepine Compositions
Administration of Benzodiazepine Compositions
Administration of Benzodiazepine Compositions
Methods and Compositions for Treating Seizure Disorders in Pediatric Patients
Application:
63/209,092 →
Treatment of Cerebral Cavernous Malformations and Cerebral Aneurysms with Rho Kinase Inhibitors
Intranasal Epinephrine Formulations and Methods for the Treatment of Disease
Methods and Compositions for Rapid Delivery of Anti-Seizure Therapeutics
Application:
63/276,760 →
Methods and Compositions for Rapid Delivery of Anti-Seizure Therapeutics
Application:
17/570,535 →
Publication:
US US20220218598A1
Compositions and Methods for Single Dose Anti-Seizure Therapeutics
Application:
63/276,761 →
Administration of Benzodiazepine Compositions
Intranasal Olanzapine Formulations and Methods of Their Use
Application:
63/323,592 →
Rho Kinase Inhibitor Ba-1049 (R) and Active Metabolites Thereof
Methods and Compositions for Increasing Interseizure Cluster Interval Duration
Application:
63/284,033 →
Methods, Parenteral Pharmaceutical Formulations, and Devices for the Prevention of Opioid Overdose
Application:
17/319,221 →
Publication:
US US20210275444A1
Compositions and Methods for the Treatment of Opioid Overdose
Application:
63/229,300 →
Compositions and Methods for the Treatment of Opioid Overdose
Application:
17/881,191 →
Publication:
US US20220387306A1
Administration of Benzodiazepine Compositions
Application:
18/062,062 →
Publication:
US US20230104144A1
Intranasal Olanzapine Formulations and Methods of Their Use
Methods and Compositions for Treating Seizure Disorders in Pediatric Patients
Polymorphs of Substituted Isoquinoline-Based Rho Kinase Inhibitors
Application:
63/350,936 →
Absorption Enhancers for Intranasal Interferon Administration
Absorption Enhancers for Intranasal Administration
Pharmaceutical Composition Including Alkyl Glycoside and an Anti-Seizure Agent
Antibacterial Compositions for Drug Administration
Controlled Release Formulations
Controlled Release Formulations
Intranasal Administration of Active Agents to the Central Nervous System
Compositions for Drug Administration
Alkylglycoside Compositions for Drug Administration
Compositions for Drug Administration
Compositions for Drug Administration
Compositions for Oral Drug Administration
Stabilizing Alkylglycoside Compositions and Methods Thereof
Stabilizing Alkylglycoside Compositions and Methods Thereof
Stabilizing Alkylglycoside Compositions and Methods Thereof
Stabilizing Alkylglycoside Compositions and Methods Thereof
Stabilizing Alkylglycoside Compositions and Methods Thereof
Stabilizing Alkylglycoside Compositions and Methods Thereof
Stabilizing Alkylglycoside Compositions and Methods Thereof
Stabilizing Alkylglycoside Compositions and Methods Thereof
Stabilizing Alkylglycoside Compositions and Methods Thereof
Stabilizing Alkylglycoside Compositions and Methods Thereof
Compositions for Drug Administration
Absorption Enhancers for Drug Administration
Stabilizing Alkylglycoside Compositions and Methods Thereof
Compositions for Drug Administration
Intranasal Epinephrine Formulations and Methods for the Treatment of Disease
Multimodal Particulate Formulations
Administration of Benzodiazepine Compositions
Administration of Benzodiazepine Compositions
4-Substituted Piperidine Derivatives
Treatment of Cerebral Cavernous Malformations and Cerebral Aneurysms with Rho Kinase Inhibitors
Treatment of Cerebral Cavernous Malformations and Cerebral Aneurysms with Rho Kinase Inhibitors
Treatment of Cerebral Cavernous Malformations and Cerebral Aneurysms with Rho Kinase Inhibitors
Rho Kinase Inhibitor Ba-1049 (R) and Active Metabolites Thereof
Rho Kinase Inhibitor Ba-1049 (R) and Active Metabolites Thereof
Kinase Inhibitors for Treatment of Disease
Intranasal Epinephrine Formulations and Methods for the Treatment of Disease
Rho Kinase Inhibitor Ba-1049 (R) and Active Metabolites Thereof
Compositions and Methods for the Treatment of Opioid Overdose
Oil-Soluble Drug Containing Compositions and Methods of Use Thereof
PCT:
PCT/US2020/033201 ↗
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 7, 2019
From: MAGGIO, EDWARD T.
To: AEGIS THERAPEUTICS, LLC
Reel/Frame 050644/0136 →
Assignment of Assignor's Interest
Oct 7, 2019
From: CARTT, STEVE; MEDEIROS, DAVID
To: HALE BIOPHARMA VENTURES, LLC
Reel/Frame 050644/0198 →
Assignment of Assignor's Interest
Oct 16, 2019
From: MAGGIO, EDWARD T.
To: AEGIS THERAPEUTICS, LLC
Reel/Frame 050740/0096 →
Assignment of Assignor's Interest
Oct 16, 2019
From: CRYSTAL, ROGER; AGRAWAL, ARVIND
To: OPIANT PHARMACEUTICALS, INC.
Reel/Frame 050740/0107 →
Assignment of Assignor's Interest
Nov 11, 2019
From: MAGGIO, EDWARD T.
To: AEGIS THERAPEUTICS, LLC
Reel/Frame 050976/0039 →
Assignment of Assignor's Interest
Jul 24, 2020
From: MAGGIO, EDWARD T.
To: AEGIS THERAPEUTICS, LLC
Reel/Frame 053305/0980 →
Assignment of Assignor's Interest
Jul 24, 2020
From: MAGGIO, EDWARD T.
To: AEGIS THERAPEUTICS, LLC
Reel/Frame 053306/0366 →
Assignment of Assignor's Interest
Aug 6, 2020
From: CRYSTAL, ROGER; ELLISON, MARK; SKOLNICK, PHIL
To: OPIANT PHARMACEUTICALS, INC.
Reel/Frame 053419/0829 →
Assignment of Assignor's Interest
Aug 6, 2020
From: MAGGIO, EDWARD T.
To: AEGIS THERAPEUTICS, LLC
Reel/Frame 053419/0262 →
Assignment of Assignor's Interest
Dec 3, 2020
From: CRYSTAL, ROGER
To: OPIANT PHARMACEUTICALS, INC.
Reel/Frame 054526/0623 →
Assignment of Assignor's Interest
Dec 3, 2020
From: MAGGIO, EDWARD T.
To: AEGIS THERAPEUTICS, LLC
Reel/Frame 054526/0647 →
Security Interest
Dec 10, 2020
From: OPIANT PHARMACEUTICALS, INC.
To: PONTIFAX MEDISON FINANCE GP, L.P.
Reel/Frame 054602/0192 →
Assignment of Assignor's Interest
Jan 14, 2021
From: MAGGIO, EDWARD T.
To: AEGIS THERAPEUTICS LLC
Reel/Frame 054915/0209 →
Assignment of Assignor's Interest
Jan 14, 2021
From: CRYSTAL, ROGER
To: OPIANT PHARMACEUTICALS, INC.
Reel/Frame 054915/0020 →
Assignment of Assignor's Interest
Jan 14, 2021
From: SKOLNICK, PHIL
To: OPIANT PHARMACEUTICALS, INC.
Reel/Frame 054915/0123 →
Assignment of Assignor's Interest
Mar 18, 2021
From: MAGGIO, EDWARD T.
To: NEURELIS, INC.
Reel/Frame 055633/0147 →
Assignment of Assignor's Interest
Mar 18, 2021
From: MADDEN, STUART
To: NEURELIS, INC.
Reel/Frame 055634/0171 →
Assignment of Assignor's Interest
Apr 6, 2021
From: HALE BIOPHARMA VENTURES, LLC
To: NEURELIS, INC.
Reel/Frame 055835/0062 →
Assignment of Assignor's Interest
May 13, 2021
From: CRYSTAL, ROGER; SKOLNICK, PHIL
To: OPIANT PHARMACEUTICALS, INC.
Reel/Frame 056227/0902 →
Nunc Pro Tunc Assignment
Jun 8, 2021
From: NEURELIS, INC.
To: AEGIS THERAPEUTICS, LLC
Reel/Frame 056514/0844 →
Nunc Pro Tunc Assignment
Jun 8, 2021
From: MAGGIO, EDWARD T.
To: NEURELIS, INC.
Reel/Frame 056514/0791 →
Assignment of Assignor's Interest
Jun 16, 2021
From: CARRAZANA, ENRIQUE J.
To: NEURELIS, INC.
Reel/Frame 056563/0553 →
Assignment of Assignor's Interest
Jun 16, 2021
From: RABINOWICZ, ADRIAN L.
To: NEURELIS, INC.
Reel/Frame 056563/0500 →
Assignment of Assignor's Interest
Jul 7, 2021
From: ROSEN, KENNETH M.; RIESINGER, STEVEN WAYNE; MCKERRACHER, LISA; BOND MORITZ, LISA
To: BIOAXONE BIOSCIENCES, INC.
Reel/Frame 056773/0985 →
Assignment of Assignor's Interest
Jul 21, 2021
From: ROSEN, KENNETH M.; ABBINANTI, MATTHEW D.; RUSCHEL, JOERG; MCKERRACHER, LISA
To: BIOAXONE BIOSCIENCES, INC.
Reel/Frame 056932/0377 →